Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 2:54 PM
Ignite Modification Date:
2025-12-25 @ 1:20 PM
NCT ID:
NCT03338959
Group ID:
EG000
Title:
Treatment (Pembrolizumab, Radiation Therapy)
Description:
Patients receive pembrolizumab IV over 30 minutes on day 1. Cycles repeat every 3 weeks for 3 months in the absence of disease progression or unacceptable toxicity. Patients also undergo radiation therapy daily for 5-6 weeks.
Pembrolizumab: Given IV
Radiation Therapy: Undergo radiation therapy
Deaths Number Affected:
0
Deaths Number At Risk:
None
Serious Number Affected:
5
Serious Number At Risk:
27
Other Number Affected:
17
Other Number At Risk:
27
Study:
NCT03338959
Results Section:
NCT03338959
Adverse Events Module:
NCT03338959